Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference49 articles.
1. Al-Abd AM, Alamoudi AJ, Abdel-Naim AB, Neamatallah TA, Ashour OM (2017) Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies—a review. J Adv Res 8:591–605. https://doi.org/10.1016/j.jare.2017.06.006
2. Ansari D, Tingstedt B, Andersson B, Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M, Andersson R (2016) Pancreatic cancer: yesterday, today and tomorrow. Future Oncol 12:1929–1946. https://doi.org/10.2217/fon-2016-0010
3. Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, DelGiorno KE, Carpenter ES, Halbrook CJ, Hall JC (2012) EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 22:304–317. https://doi.org/10.1016/j.ccr.2012.07.024
4. Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K (2022) MMP9: a tough target for targeted therapy for cancer. Cancers 14:1847. https://doi.org/10.3390/cancers14071847
5. Brune K, Abe T, Canto M, O’Malley L, Klein AP, Maitra A, Adsay NV, Fishman EK, Cameron JL, Yeo CJ (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30:1067